BNP Paribas Exane Downgrades Organon & Co. (OGN) to Neutral Post Acquisition
Tweet
Share
E-mailGet Alerts OGN Hot Sheet
Price: $13.77 +0.07%
Rating Summary:
2 Buy, 6 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
2 Buy, 6 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
BNP Paribas Exane analyst Navaan Ty downgraded Organon & Co. (NYSE: OGN) from Outperform to Neutral.
For an analyst ratings summary and ratings history on Organon & Co. click here. For more ratings news on Organon & Co. click here.
Shares of Organon & Co. closed at $13.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E Corp, Edison spike on chatter
- Action Behavior Centers' Family Advocacy Team Meets with Congressional Leaders in Washington, D.C., to Discuss Access to ABA Therapy for Autism
- Apple new CEO Ternus teases "phenomenal" iPhone launch in first memo
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
